H-1B Filings
6
Established sponsor. DOL labor condition applications on file.
Novo Nordisk Pharmaceutical Industries, LP in NC (Manufacturing) is a sponsorship-and-safety profile: 6 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
Novo Nordisk Pharmaceutical Industries, LP (NC): · 6 H-1B LCAs at a $130,042 disclosed median · OSHA Grade C (DART 1.12)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Novo Nordisk Pharmaceutical Industries, LP in NC carries 6 H-1B wage filings on record, a $130,042 median wage (above the $124,488 national median), a middling C OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #7,640 of 51,370 sponsors in this corpus (about the 83rd percentile), and disclosed median wage sits at the 55th percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
H-1B Filings
6
Established sponsor. DOL labor condition applications on file.
Median H-1B Salary
$130,042
Near national median. Across 6 disclosed positions
OSHA Safety Grade
Grade C · DART 1.12
Near industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where Novo Nordisk Pharmaceutical Industries, LP's H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$130,042 Top 45% higher than 55% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
| Field | Value | Source |
|---|---|---|
| Employer Name | Novo Nordisk Pharmaceutical Industries, LP | DOL OFLC / OSHA |
| Industry | Manufacturing | NAICS / DOL |
| State | NC | U.S. Federal Records |
| H-1B Filings | 6 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $130,042 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | C | OSHA ITA |
| OSHA DART Rate | 1.12 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
Novo Nordisk Pharmaceutical Industries, LP's values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in NC (Manufacturing). In this corpus, H-1B filing volume ranks #7,640 of 51,370 sponsors in this corpus (about the 83rd percentile); disclosed median wage sits at the 55th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 51% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Manager, Facilities Engineering - OFP | $152,000 |
| Supply Chain Engineer | $135,000 |
| QA Area Specialist IV | $130,042 |
| Associate Manager, Quality Control Chemistry | $128,000 |
| Validation Area Specialist III - Virginia | $125,000 |
| Quality Control Analyst II OFP | $82,000 |
Momentum is the headline: FY2025 filings (3) rose 200% from FY2024 (1), one of the sharper year-over-year jumps in the corpus.
Novo Nordisk Pharmaceutical Industries, LP in NC (Manufacturing) filed 6 H-1B labor condition applications at a $130,042 disclosed median — a top-tercile sponsorship footprint in this corpus.
No WARN Act mass-layoff notices are on file for Novo Nordisk Pharmaceutical Industries, LP among Manufacturing employers we track.
A $130,042 disclosed median lands near the middle of the wage distribution (55th percentile vs $124,488 nationally).
DART 1.1 tracks close to the 1.1 sector average (Grade C).
Novo Nordisk Pharmaceutical Industries, LP's DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 13.
Where Novo Nordisk Pharmaceutical Industries, LP sits
Across the 201 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Novo Nordisk Pharmaceutical Industries, LP files more petitions than 0% of them and discloses a higher median wage than 40%, the selective, below-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (6 filings · $130,042 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 42; the brand marker is Novo Nordisk Pharmaceutical Industries, LP. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
Novo Nordisk Pharmaceutical Industries, LP's nearest H-1B-filing peers in Manufacturing (home state NC). Each card links to that employer's federal-records profile.
Two federal-records peer sets for Novo Nordisk Pharmaceutical Industries, LP, both outside NC so the neighborhoods are not the same-industry VsCard above.
Nearest injury-rate peers outside NC (DART 1.12 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
What to check before working with Novo Nordisk Pharmaceutical Industries, LP
For Novo Nordisk Pharmaceutical Industries, LP, read sponsorship pay (6 H-1B LCAs, median $130,042) next to the OSHA safety grade (C).
Novo Nordisk Pharmaceutical Industries, LP's figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, Novo Nordisk Pharmaceutical Industries, LP's disclosed median of $130,042 sits at the 55th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
Novo Nordisk Pharmaceutical Industries, LP has 6 H-1B filings on record, ranking #7,640 of 51,370 sponsors in this corpus (about the 83rd percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Novo Nordisk Pharmaceutical Industries, LP carries Grade C from its establishment injury record (13 injuries on file; DART 1.12). That DART rate is safer than roughly 51% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.